Claudin-4免疫化学在浆膜腔积液细胞学中鉴别转移性癌与间皮病变的诊断准确性:系统综述与荟萃分析
该研究首次通过荟萃分析评估Claudin-4免疫化学在浆膜腔积液细胞病理学中区分转移性癌与间皮瘤或反应性间皮细胞的诊断准确性。纳入14项观察性研究,汇总敏感度为98.02%(95%CI 93.96%-99.37%),特异度为99.72%(95%CI 97.36%-99.97%),诊断比值比为1660.5(95%CI 760.0-3627.8),无异质性(I2=0%)。结论认为Claudin-4可作为单一泛癌免疫化学生物标志物用于该鉴别诊断。
要点
- Claudin-4免疫化学在浆膜腔积液细胞学中鉴别转移性癌与间皮病变具有高诊断准确性。
- 汇总敏感度98.02%,特异度99.72%,诊断比值比1660.5,研究间无异质性。
- 所有纳入研究均使用3E2C1克隆,Claudin-4可作为单一泛癌标志物。
核心结论
- Claudin-4免疫化学在浆膜腔积液细胞学中鉴别转移性癌与间皮瘤或反应性间皮细胞具有高诊断准确性,可作为单一泛癌免疫化学生物标志物。
主要发现
- 汇总敏感度为98.02%(95% CI, 93.96%-99.37%),汇总特异度为99.72%(95% CI, 97.36%-99.97%)。
- 汇总诊断比值比为1660.5(95% CI, 760.0-3627.8)。
- 纳入研究间无统计学异质性(I2 = 0%, τ2 = 0)。
- 所有14项研究均使用3E2C1克隆。
关键数值与推荐
- Claudin-4免疫化学阳性结果提示癌而非间皮病变的 diagnostic odds ratio 为1660.5(95% CI, 760.0-3627.8)。
临床怎么用
- 在浆膜腔积液细胞学中,可使用Claudin-4免疫化学作为单一泛癌标志物辅助鉴别转移性癌与间皮瘤或反应性间皮细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Distinguishing metastatic carcinomas from mesotheliomas or reactive mesothelial cells in pleural, peritoneal, and pericardial effusions is a common diagnostic problem cytopathologists encounter. OBJECTIVE.—: To perform the first meta-analysis on the pooled diagnostic accuracy of claudin-4 immunochemistry in serous effusion cytopathology. DESIGN.—: This report followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for diagnostic test accuracy studies. Three databases (PubMed, Scopus, and the Cochrane Library) were searched until October 9, 2023, followed by study selection using specific inclusion and exclusion criteria and data extraction. The study quality assessment was performed by using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. Statistical analysis was performed by using R to calculate the pooled sensitivity and specificity of claudin-4 immunochemistry. In addition, the diagnostic odds ratio was measured, representing the odds ratio of a positive result indicating a carcinoma rather than a mesothelial process in serous effusion cytology. RESULTS.—: Fourteen observational studies, published between 2011 and 2023, fulfilled the selection criteria and were included. All 14 studies used the 3E2C1 clone. Claudin-4 immunochemistry showed a high diagnostic accuracy in serous effusion cytology. The pooled sensitivity and specificity were 98.02% (95% CI, 93.96%-99.37%) and 99.72% (95% CI, 97.36%-99.97%), respectively. Lastly, the pooled diagnostic odds ratio was 1660.5 (95% CI, 760.0-3627.8), and no evidence of statistical heterogeneity between the included studies was found (I2 = 0%, τ2 = 0). CONCLUSIONS.—: Claudin-4 may be used as a single pan-carcinoma immunochemical biomarker in the differential diagnosis between metastatic carcinomas and mesotheliomas or reactive mesothelial cells in serous effusion cytology.
引用
- Kleinaki M, Vey JA, Awounvo S, et al. The Diagnostic Accuracy of Claudin-4 Immunochemistry in Differentiating Metastatic Carcinomas From Mesothelial Processes in Serous Effusion Cytology: A Systematic Review and Meta-analysis. Arch Pathol Lab Med. 2025. PMID: 38871358. doi:10.5858/arpa.2023-0560-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。